» Articles » PMID: 31375554

Association of Gene Polymorphisms with the Risk of Developing Type 2 Diabetes Mellitus in the Chinese Han Population

Overview
Journal Biosci Rep
Specialty Cell Biology
Date 2019 Aug 4
PMID 31375554
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of the present study was to explore the genetic association of single nucleotide polymorphisms (SNPs) in interleukin-16 () gene with type 2 diabetes mellitus (T2DM) susceptibility in a Chinese Han population. In total, 133 T2DM patients and 127 healthy controls matched by age and gender were recruited in the case-control study. gene rs4778889 and rs11556218 polymorphisms were genotyped in the two groups via polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Differences in genotype and allele distributions between groups were compared by the χ test. All the comparisons were adjusted for age, gender, and body mass index (BMI) by logistic regression. The odds ratios (ORs) and 95% confidence intervals (CIs) were used to evaluate the association strength between gene polymorphism and T2DM risk. The TG genotype and G allele frequencies of rs11556218 increased remarkably in the case group than that in controls (45.86 vs 33.86%; 29.70 vs 20.87%), and the differences reached a significant level (<0.05). After adjusting for age, gender, and BMI, the differences still reached a significant level (<0.05). Rs11556218 TG genotype carriers had a 1.769-fold increased risk of developing T2DM (OR = 1.769, 95% CI = 1.045-2.994), and G allele was also associated with an increased risk of T2DM (OR = 1.639, 95% CI = 1.087-2.471). rs4778889 polymorphism showed no significant association with T2DM risk. gene rs11556218 polymorphism was significantly associated with T2DM susceptibility in the Chinese Han population, while rs4778889 was not.

Citing Articles

Association of the Single Nucleotide Polymorphisms rs11556218, rs4778889, rs4072111, and rs1131445 of the Interleukin-16 Gene with Ovarian Cancer.

Watrowski R, Schuster E, Van Gorp T, Hofstetter G, Fischer M, Mahner S Int J Mol Sci. 2024; 25(19).

PMID: 39408600 PMC: 11477281. DOI: 10.3390/ijms251910272.


Interleukin-16 rs4072111 Polymorphism is Associated with the Risk of Peri-Implantitis in the Chinese Population.

Chen Z, Chen G Pharmgenomics Pers Med. 2021; 14:1629-1635.

PMID: 34938097 PMC: 8686223. DOI: 10.2147/PGPM.S336857.


Association of IL-16 rs11556218 T/G polymorphism with the risk of developing type 2 diabetes mellitus.

Mohammad D, Omar H, El-Abaseri T, Omar W, Abdelraheem S J Diabetes Metab Disord. 2021; 20(1):649-653.

PMID: 34222083 PMC: 8212215. DOI: 10.1007/s40200-021-00795-2.


Association of functional polymorphisms with cancer and cardiovascular disease: a meta-analysis.

de Souza V, de Alencar J, Tiaki Tiyo B, Alves H, Vendramini E, Maria Sell A Oncotarget. 2020; 11(36):3405-3417.

PMID: 32934782 PMC: 7486693. DOI: 10.18632/oncotarget.27715.

References
1.
Seegert D, Rosenstiel P, Pfahler H, Pfefferkorn P, Nikolaus S, Schreiber S . Increased expression of IL-16 in inflammatory bowel disease. Gut. 2001; 48(3):326-32. PMC: 1760149. DOI: 10.1136/gut.48.3.326. View

2.
Nakayama E, Wasi C, Ajisawa A, Iwamoto A, Shioda T . A new polymorphism in the promoter region of the human interleukin-16 (IL-16) gene. Genes Immun. 2001; 1(4):293-4. DOI: 10.1038/sj.gene.6363672. View

3.
Zak K, Kondratskaia I, Melnichenko S, Popova V . [Circulating interleukin-16 in blood of patients with metabolic syndrome and type 2 diabetes mellitus]. Lik Sprava. 2008; (5-6):46-9. View

4.
Xue H, Gao L, Wu Y, Fang W, Wang L, Li C . The IL-16 gene polymorphisms and the risk of the systemic lupus erythematosus. Clin Chim Acta. 2009; 403(1-2):223-5. DOI: 10.1016/j.cca.2009.03.016. View

5.
Meagher C, Beilke J, Arreaza G, Mi Q, Chen W, Salojin K . Neutralization of interleukin-16 protects nonobese diabetic mice from autoimmune type 1 diabetes by a CCL4-dependent mechanism. Diabetes. 2010; 59(11):2862-71. PMC: 2963545. DOI: 10.2337/db09-0131. View